Trial: 201808122

Randomized, Double-blinded Phase III Study of Cabozantinib versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus

Phase

III

Principal Investigator

Trikalinos, Nikolaos

Disease Site

Anus; Colon; Esophagus; Liver; Lung; Other Digestive Organ; Pancreas; Rectum; Small Intestine; Stomach; Unknown Sites

Learn more about this study at: clinicaltrials.gov